Latest | F'cast | |
---|---|---|
Div Yield | 1.2% | 0.0% |
Div Cover | 2.5 | 2.5 |
Op Mrgn | 23.9% | 27.1% |
ROCE | 226.1% |
Latest | F'cast | |
---|---|---|
P/E | 32.2 | 30.9 |
PEG | 4.2 | 4.4 |
Pr/Revenue | 6.1 | 4.8 |
Pr/Book | 9.2 |
Latest | F'cast | |
---|---|---|
Revenue | 7.2% | -18.2% |
PBT | 32.1% | 1.5% |
EPS | 7.7% | 7.8% |
DPS | 6.8% | -36.2% |
Year Ending | Revenue ($m) | Pre-tax ($m) | EPS | P/E | PEG | EPS Grth. | Div | Yield |
---|---|---|---|---|---|---|---|---|
31-Mar-20 | 5,179.00 | 942.00 | 103.00¢ | 28.3 | 5.7 | +5% | 47.00¢ | 1.6% |
31-Mar-21 | 5,372.00 | 1,077.00 | 103.10¢ | 31.3 | n/a | 0% | 47.00¢ | 1.5% |
31-Mar-22 | 6,288.00 | 1,447.00 | 124.50¢ | 30.7 | 1.5 | +21% | 51.75¢ | 1.4% |
31-Mar-23 | 6,619.00 | 1,174.00 | 135.10¢ | 25.5 | 3.2 | +8% | 54.75¢ | 1.6% |
31-Mar-24 | 7,097.00 | 1,551.00 | 145.50¢ | 30.7 | 3.8 | +8% | 58.50¢ | 1.3% |
a. Based on UK GAAP presentation of accounts - includes discontinued activities
Year Ending | Revenue (£m) | Pre-tax (£m) | EPS | P/E | PEG | EPS Grth. | Div | Yield |
---|---|---|---|---|---|---|---|---|
31-Mar-25 | 7,516.76 | 2,038.02 | 121.37p | 29.9 | 3.8 | +8% | 48.27p | 0.0% |
31-Mar-26 | 8,172.31 | 2,298.93 | 135.71p | 26.7 | 2.3 | +12% | 53.43p | 0.0% |
31-Mar-27 | 8,882.04 | 2,562.21 | 152.70p | 23.7 | 1.9 | +12% | 59.07p | 0.0% |
Copyright © 2025 FactSet Research Systems Inc. All rights reserved.
Additional Listing | 26-Mar-2025 | 09:40 | RNS |
Transaction in Own Shares | 21-Mar-2025 | 17:22 | RNS |
Additional Listing | 20-Mar-2025 | 09:32 | RNS |
Controversial bosses of TalkTalk and Experian ap... | 22-Jul-2014 | Daily Mail |
Experian under fire over corporate governance | 16-Jul-2014 | Guardian |
Experian in web fraud deal | 02-Oct-2013 | The Herald |
Traded | Action | Notifier | Price | Amount | Value |
---|---|---|---|---|---|
13-Mar-25 | Buy | Kathleen DeRose | 3,515.01p | 400 | £14,060.03 |
07-Feb-25 | Buy Dividends | Esther Lee | 3,915.42p | 7 | £274.08 |
Currency | UK Pounds |
Share Price | 3,624.00p |
Change Today | 50.00p |
% Change | 1.40 % |
52 Week High | 4,007.00 |
52 Week Low | 3,198.00 |
Volume | 1,358,219 |
Shares Issued | 918.00m |
Market Cap | £33,268m |
Beta | 0.01 |
RiskGrade | 148 |
Value |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
---|
Price Trend |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
---|
Income |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
---|
Growth |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
---|
Strong Buy | 5 |
Buy | 9 |
Neutral | 3 |
Sell | 1 |
Strong Sell | 0 |
Total | 18 |
Latest | Previous | |
---|---|---|
Interim | 2nd Interim | |
Ex-Div | 09-Jan-25 | 20-Jun-24 |
Paid | 07-Feb-25 | 19-Jul-24 |
Amount | 19.25¢ | 40.50¢ |
Time | Volume / Share Price |
16:35 | 114 @ 3,624.00p |
16:35 | 120 @ 3,624.00p |
16:35 | 161 @ 3,624.00p |
16:35 | 168 @ 3,624.00p |
16:35 | 146 @ 3,624.00p |
CEO | Brian Cassin |
CFO | Lloyd Pitchford |
Chair | Mike Rogers |
You are here: research